Related Experiment Videos
Ras activity regulates cyclin E degradation by the Fbw7 pathway.
Alex C Minella1, Markus Welcker, Bruce E Clurman
1Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Summary
Oncogenic Ras activity disrupts the Fbw7 pathway, impairing cyclin E degradation. This links Ras mutations to cancer by promoting genetic instability through reduced cyclin E proteolysis.
Area of Science:
- Cellular Biology
- Molecular Oncology
- Biochemistry
Background:
- The Fbw7 ubiquitin ligase targets cyclin E for degradation, a process crucial for preventing genetic instability and tumorigenesis.
- Fbw7 is a tumor suppressor frequently mutated in cancers, but other mechanisms may also impair its function.
- Dysregulation of cyclin E proteolysis is implicated in cancer development.
Purpose of the Study:
- To investigate the role of oncogenic Ha-Ras activity in regulating cyclin E degradation via the Fbw7 pathway.
- To elucidate the specific Ras-activated signaling pathways involved in modulating cyclin E turnover.
- To determine how Ras-mediated inhibition of cyclin E proteolysis contributes to genetic instability and tumorigenesis.
Main Methods:
- Utilized cell-based assays to examine the impact of activated and inhibited Ras signaling on cyclin E protein levels and degradation.
- Investigated the interaction between cyclin E and Fbw7 under conditions of altered Ras activity.
- Assessed the role of the mitogen-activated protein kinase (MAPK) pathway in Ras-mediated regulation of cyclin E.
- Evaluated the effect of oncogenic Ras on cyclin E-induced genetic instability.
Main Results:
- Oncogenic Ha-Ras activity was found to inhibit Fbw7-mediated cyclin E degradation, leading to increased cyclin E abundance.
- Inhibition of normal Ras activity resulted in decreased cyclin E levels.
- Activation of the MAPK pathway was identified as the key Ras-dependent mechanism suppressing cyclin E turnover.
- Activated Ha-Ras impaired the binding of cyclin E to Fbw7 and reduced cyclin E ubiquitination.
- Oncogenic Ras potentiated cyclin E-driven genetic instability, particularly when cyclin E degradation was compromised by Fbw7.
Conclusions:
- Ras activity directly regulates Fbw7-mediated proteolysis of cyclin E.
- Impaired cyclin E proteolysis, driven by Ras activity, represents a novel mechanism contributing to Ras-driven tumorigenesis.
- Targeting the Ras-Fbw7-cyclin E axis may offer therapeutic strategies for cancers with Ras mutations.